Vicky Chappell, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Sherman, TXNPI 1366547390
Payments from drug & device makers
Across 148 payments — averaging $40.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$1K
- Abiomed$925
- Siemens Medical Solutions USA, Inc.$435
- Stryker$388
- W. L. Gore & Associates, Inc.$138
- plus $395 from 9 others
What the payments were for
- Travel & lodging$4678%
- Food & beverage$5,45692%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 77 | $2,518 |
| Abbott | 22 | $1,123 |
| Abiomed | 19 | $925 |
| Siemens Medical Solutions USA, Inc. | 5 | $435 |
| Stryker | 3 | $388 |
| W. L. Gore & Associates, Inc. | 6 | $138 |
| Cvrx, Inc. | 5 | $79 |
| Atricure, Inc. | 2 | $78 |
| Johnson & Johnson | 3 | $73 |
| Silk Road Medical, Inc. | 1 | $66 |
| Potrero Medical, Inc. | 1 | $32 |
| Covidien LP | 1 | $23 |
| Philips North America LLC | 1 | $18 |
| Biomerieux Inc | 1 | $16 |
| Teleflex LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$706
- Confirm Rx$385
- CHROMOPHARE F300$354
- Artis pheno$327
- Impella$246
- CoreValve Evolut$230
- AVEIR$161
How this compares
$5,923 in reported general payments places this provider in the 45th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 61 | $320 |
| Potassium Chloride | 22 | $99 |
| Amiodarone Hcl | 21 | $98 |
| Oxycodone Hcl | 14 | $95 |
| Tramadol Hcl | 19 | $74 |
| Metoprolol Tartrate | 43 | $56 |
| Furosemide | 21 | $32 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Sherman
- Robert SmithPlano$2.9M
- Michael ReardonHouston$2.7M
- William RyanPlano$2.1M
- Faraz KerendiAustin$1.6M
- Robert HebelerDallas$1.2M
- William BrinkmanPlano$1.2M
- Robert RipleyHouston$817K
- Michael MackPlano$796K
- Katherine HarringtonPlano$723K
- Danny RamzyHouston$620K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.